Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 33 Issue 1
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2015  >  33(1): 17-19,27

CHENG Hao, RUI Yaocheng, ZHANG Yuefan, LI Tiejun. Research progress of bioactive peptide monocyte locomotion inhibitory factor[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 17-19,27. doi: 10.3969/j.issn.1006-0111.2015.01.005
Citation: CHENG Hao, RUI Yaocheng, ZHANG Yuefan, LI Tiejun. Research progress of bioactive peptide monocyte locomotion inhibitory factor[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 17-19,27. doi: 10.3969/j.issn.1006-0111.2015.01.005
shu

Research progress of bioactive peptide monocyte locomotion inhibitory factor

doi: 10.3969/j.issn.1006-0111.2015.01.005
  • 1.

    School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China

  • 2.

    Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 3.

    School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China;Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • Received Date: 2013-11-12
  • Rev Recd Date: 2014-04-21
  • Monocyte locomotion inhibitory factor(MLIF)was an anti-inflammatory pentapeptide produced by Entamoeba histolytica.In vivo and in vitro study showed that MLIF displayed anti-inflammatory and immune protection effects and MLIF had protective effects on rheumatoid arthritis,nerve injury,myocardial ischemia,cerebral ischemia and Alzheimer's disease.Studies had shown that MLIF regulated inflammatory response and immune protection through NF-κB and MAPK signal pathways.The sources and biological activities of MLIF were reviewed in this paper.
  • [1] 王竹青, 李八方.生物活性肽及其研究进展[J].中国海洋药物杂志,2010,29(2):60-68.
    [2] Kretschmer RR,Collado ML,Pacheco MG,et al.Inhibition of human monocyte locomotion by products of Entamoeba histolytica[J].Parasite Immunol,1985,7:527-543.
    [3] López-Osuna M,Cárdenas G,Isario J,et al.Induction of protective immunity against experimental amebic abscess of the liver (EAAL) using the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica:a preliminary report[J].Arch Med Res,2000, 31(4):S110-S111.
    [4] Jiang HF,Li J,Zhao X,et al.Determination of an unstable pentapeptide,monocyte locomotion inhibitory factor,in dog blood by LC-MS/MS:application to a pharmacokinetic study[J].J Pharm Biomed Anal,2013,83:305-313.
    [5] Giménez-Schr JA,Arenas E,Díaz L,et al.Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica on the expression of cell adhesion molecules in the skin of guinea pigs[J].Arch Med Res,2000,31(4 Suppl):S92-S93.
    [6] Godina-Gonzalez S,Furuzawa-Carballeda J,Utrera-Barillas D,et al.Amebic monocyte locomotion inhibitory factor peptide ameliorates inflammation in CIA mouse model by downregulation of cell adhesion,inflammation/chemotaxis,and matrix metalloproteinases genes[J].Inflamm Res,2010,59(12):1041-1051.
    [7] Velázquez JR,Garibay-Martínez L,Martínez-Tejada P,et al.An amebic anti-inflammatory peptide down-regulates ex vivo IL-1β expression in patients with rheumatoid arthritis[J].Reumatol Clin,2012,8(6):315-320.
    [8] 章越凡,芮耀诚,李铁军,等.五肽代谢物在制备抗炎药物中的应用[P].中国专利,CN 103611149 A,2014-03-05.
    [9] Utrera-Barillas D,Velazquez JR,Enciso A,et al.An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines[J].Parasite Immunol,2003,25(10),475-482.
    [10] Silva-García R,Estrada-García I,Ramos-Payán R,et al.The effect of an anti-inflammatory pentapeptide produced by Entamoeba histolytica on gene expression in the U-937 monocytic cell line[J].Inflamm Res,2008,57(4):145-150.
    [11] Morales-Martínez ME,Silva-García R,Soriano-Correa C,et al.The Cys-Asn-Ser carboxyl-terminal end group is the pharmacophore of the amebic anti-inflammatory monocyte locomotion inhibitory factor (MLIF)[J].Mol Biochem Parasitol,2008,158(1):46-51.
    [12] Barrientos-Salcodo C,Rico-Rosillo G,Giménez-Scherer JA,et al.Computational study of the electronic structure characterization of a novel anti-inflammatory tripeptide derived from monocyte locomotion inhibitory factor (MLIF)-pentapeptide[J].Eur J Med Chem,2009,44 (8):3114-3119.
    [13] Rojas-Dotor S,Perez-Ramos J,Gimenez-Scherer,et al.Effect of the monocyte locomotion inhibitory factor (MLIF) produced by E.histolityca on cytokines and chemokine receptors in T CD4+ lymphocytes[J].Bio Res,2009,42 (4):415-425.
    [14] Rojas-Dotor S,Rico G,Pérez J,et al.Cytokine expression in CD4+ cells exposed to the monocyte locomotion inhibitory factor produced by Entamoeba histolytica[J].Parasitol Res,2006,98(5):493-495.
    [15] Rico G,Leandro E,Rojas S,et al.The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes[J].Parasitol Res,2003,90 (4),264-267.
    [16] Zhang Y,Chen J,Li F,et al.A pentapeptide monocyte locomotion inhibitory factor protects brain ischemia injury by targeting the eEF1A1/endothelial nitric oxide synthase pathway[J].Stroke,2012,43(10):2764-2773.
    [17] 杨鹏远,芮耀诚,章越凡.多肽小分子在制备防治缺血性脑血管病药物中的应用[P].中国专利,CN 101361961 A,2009-2-11.
    [18] 章越凡,芮耀诚,李铁军,等.五肽代谢物及其在制备防治缺血性脑血管疾病药物中的应用[P].中国专利,CN 103611149 A,2014-03-05.
    [19] 芮耀诚,李铁军,杨鹏远,等.多肽小分子MLIF在制备防治心肌缺血药物中的应用[P].中国专利,CN 101612384A,2009-12-30.
    [20] 李铁军,芮耀诚,章越凡,等.一种五肽的部分代谢物用于制备抗心肌缺血产品的新用途[P].中国专利,CN 103203009 A,2013-07-17.
    [21] Yao J,Xu Y,Ji F,et al.Protective effects of MLIF analogs on cerebral ischemia-reperfusion injury in rats[J].Peptides,2011,32(5):1047-1054.
    [22] Bermeo G,Ibarra A,García E,et al.Monocyte locomotion inhibitory factor produced by E.histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord[J].Biomed Res Int,2013,2013:340727.
    [23] 李铁军,芮耀诚,章越凡,等.一种五肽及其代谢物用于制备抗痴呆产品的新用途[P].中国专利,CN 103191407,2013-07-10.
    [24] Silva-Garcia R,Rico-Rosillo G.Anti-inflammatory defense mechanisms of Entamoeba histolytica[J].Inflamm Res,2011,60(2):111-117.
    [25] Sasaki M,Kashima M,Watanabe A,et al.Differential regulation of metalloproteinase production,proliferation and chemotaxis of human lung fibroblasts by PDGF,interleukin-1beta and TNF-alpha[J].Mediators Inflamm,2000,9(3-4):155-160.
    [26] Gharaee-Kermani M,Phan SH.Role of cytokines and cytokine therapy in wound healing and fibrotic diseases[J].Curr Pharm Des,2001,7(11):1083-1103.
    [27] Velazquez JR.The monocyte locomotion inhibitory factor an anti-inflammatory peptide;therapeutics originating from amebic abscess of the liver[J].Recent Pat Endocr Metab Immune Drug Discov,2011,5(1):7-12.
    [28] Silva-García R,Rico-Rosillo G.Anti-inflammatory defense mechanisms of Entamoeba histolytica[J].Inflamm Res,2011,60(2):111-117.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2910) PDF downloads(134) Cited by()

Related
Proportional views

Research progress of bioactive peptide monocyte locomotion inhibitory factor

doi: 10.3969/j.issn.1006-0111.2015.01.005
  • 1. School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
  • 2. Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
  • 3. School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China;Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
  • Received Date: 2013-11-12
  • Rev Recd Date: 2014-04-21

Abstract: Monocyte locomotion inhibitory factor(MLIF)was an anti-inflammatory pentapeptide produced by Entamoeba histolytica.In vivo and in vitro study showed that MLIF displayed anti-inflammatory and immune protection effects and MLIF had protective effects on rheumatoid arthritis,nerve injury,myocardial ischemia,cerebral ischemia and Alzheimer's disease.Studies had shown that MLIF regulated inflammatory response and immune protection through NF-κB and MAPK signal pathways.The sources and biological activities of MLIF were reviewed in this paper.

CHENG Hao, RUI Yaocheng, ZHANG Yuefan, LI Tiejun. Research progress of bioactive peptide monocyte locomotion inhibitory factor[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 17-19,27. doi: 10.3969/j.issn.1006-0111.2015.01.005
Citation: CHENG Hao, RUI Yaocheng, ZHANG Yuefan, LI Tiejun. Research progress of bioactive peptide monocyte locomotion inhibitory factor[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(1): 17-19,27. doi: 10.3969/j.issn.1006-0111.2015.01.005
shu

    HTML

Reference (28)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return